What's in Synermore Biologics Co., Ltd.'s pipeline?

Synermore Biologics Co., Ltd. has 8 drugs in our index: 2 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 5 in Phase 1.

Which companies overlap with Synermore Biologics Co., Ltd.'s portfolio?

Top competitors by shared drug class: Merck Sharp & Dohme LLC, Asan Medical Center, Bio-Thera Solutions, Celltrion, Pfizer.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/synermore-biologics-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Synermore Biologics Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Synermore Biologics Co., Ltd. pipeline: 2 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 1 Phase 3 0 Phase 2 5 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
RabAvert	RabAvert	marketed
Imovax	Imovax	marketed			Other
SYN023	SYN023	phase 3	PD-1 inhibitor	PD-1	Oncology

Therapeutic area mix

Immunology · 1
Oncology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Merck Sharp & Dohme LLC · 2 shared drug classes
Asan Medical Center · 2 shared drug classes
Bio-Thera Solutions · 2 shared drug classes
Celltrion · 2 shared drug classes
Pfizer · 2 shared drug classes
UNICANCER · 2 shared drug classes
Addpharma Inc. · 1 shared drug class
Abbott · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Synermore Biologics Co., Ltd.:

Cite this brief

Drug Landscape (2026). Synermore Biologics Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/synermore-biologics-co-ltd. Accessed 2026-05-17.